CAPR
Ticker
Capricor Therapeutics, Inc.
CAPR · Healthcare · Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based th…Capricor Therapeutics, Inc. (CAPR), in the Healthcare sector, has 8 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 0 purchases and 8 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Jun 25 and filed Jun 29. The most active filer was Anthony Bergmann with 3 filings.
Add to watchlistFilings, ttm
8
0 buys · 8 sells
Traders, ttm
3
3 insiders
Volume, ttmiDollar value disclosed in the window
$8.3M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Jun 25
Filed Jun 29
ADViAverage daily dollar volume
$33.1M
market data
Share price · 12M
$4.12 (-32.3%)
Adjusted for splits and dividends.
Volume by month
Buys $0
Sells $8.3M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
ABRecent filings
Anthony BergmannSALE
CHIEF FINANCIAL OFFICER
$732K24,100 sh × $30.38
Exec Jun 25
Filed Jun 29 · 5:30 PM ET Karen KrasneySALE EVP, GENERAL COUNSEL $732K
24,100 sh × $30.38
Exec Jun 25
Filed Jun 29 · 5:30 PM ET Anthony BergmannSALE CHIEF FINANCIAL OFFICER $792K
25,000 sh × $31.70
Exec May 1
Filed May 4 · 5:30 PM ET Karen KrasneySALE EVP, GENERAL COUNSEL $792K
25,000 sh × $31.70
Exec May 1
Filed May 4 · 5:30 PM ET Karimah Es SabarSALE Director $241K
7,529 sh × $32.00
Exec Apr 2
Filed Apr 3 · 5:30 PM ET Anthony BergmannSALE CHIEF FINANCIAL OFFICER $753K
25,000 sh × $30.13
Exec Mar 31
Filed Apr 1 · 5:30 PM ET Karimah Es SabarSALE Director $3.5M
115,000 sh across 2 lots
Exec Mar 31
Filed Apr 1 · 5:30 PM ET Karen KrasneySALE EVP, GENERAL COUNSEL $753K
25,000 sh × $30.12
Exec Mar 31
Filed Apr 1 · 5:30 PM ET Nippon Shinyaku Co LtdPURCHASE 10% owner $15.0M
2,798,507 sh × $5.36
Exec Sep 20 2024
Filed Sep 24 2024 · 5:30 PM ET